Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013

Name: Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
Creator: KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Published: 2025-01-01T00:00:00+08:00

Harvard Dataverse2025-01-01 更新2026-04-09 收录

镰状细胞病治疗

临床试验数据

数据链接：

https://dataverse.harvard.edu/citation?persistentId=doi:10.7910/DVN/DKR3LX 数据链接链接失效反馈

官方服务：

资源简介：

The package contains extended data for the protocol titled "<strong><i>Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013</strong></i>"

提供机构：

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya

创建时间：

2025-01-01